Recidivism rates for offenders constantly reflect disappointment. In an effort to reduce the rate of recidivism, the SSRI (selective seroton in reuptake inhibitor) medication paroxetine was attempted with a small group of offenders in a community-based program About half the offenders dropped out after one or two sessions, but 14 completed 3 months of treatment. These had a reduction in depressive and obsessive-conpulsive disorder symptoms, but it is difficult to determine the impact on the total rehabilitation program for the offenders. The implications for further research and clinical work are discussed
Get full access to this article
View all access options for this article.
References
1.
Antonowicz, D. H. , & Ross, R. R. (1994). Essential components of successful rehabilitation programs for offenders. International Journal of Offender Therapy and Comparative Criminology, 38, 97-104.
2.
Dubovsky, S. L. , & Thomas, M. (1995). Serotonergic mechanisms and current and future psychiatric practice. Journal of Clinical Psychiatry, 56(Suppl. 2), 38-48.
3.
Golden, R. N. , Gilmore, J. H., Cofrigan, M.H.N., Ekstrom, R. D., Knight, B. T., & Garbutt, J. C. (1991). Serotonin, suicide and aggression: Clinical studies. Journal of Clinical Psychiatry, 52(Suppl. 12), 61-69.
4.
Goodman, W. K. , Price, L. H., & Rasmussen, S. A. (1989). The Yale-Brown Objessive-Compulsive Scale 1: Development, use and reliability. Archives of General Psychiatry, 46, 1006-1011.
5.
Graham, K. R. (1993). Towards a better understanding and treatment of sex offenders. International Journal of Offender Therapy and Comparative Criminology, 37, 41-57.
6.
Hollander, E. , & Wong, C. M. (1995). Body dysmorphic disorder, pathological gambling and sexual compulsion. Journal of Clinical Psychiatry, 56(Suppl. 4), 7-12.
7.
Kafka, M. P. (1994). Sertraline pharmacotherapy for paraphilias and paraphilia-related disorders: An open trial. Annals of Clinical Psychiatry, 6, 189-195.
8.
Kaye, W. H. , & Weltzin, T. E. (1991). Serotonin activity in anorexia and bulimia nervosa: Relationship to the modulation and feeling of mood. Journal of Clinical Psychiatry, 15(Suppl. 2), 41-48.
9.
Kramner, P. (1993). Listening to Prozac. New York: Penguin.
10.
Markovitz, P. J. , Calabrese, J. R., Schulz, S. C., & Meltzer, H. Y. (1991). Fluoxetine in the treatment of borderline and schizotypal personality disorders. American Journal of Psychiatry, 148, 1061-1067.
11.
Myers, J. K. , & Weissman, M. M. (1980). Use a self-report symptom scale to detect the depressive syndrome. American Journal of Psychiatry, 137, 1081-1084.
12.
Pies, R. W. , & Popli, A. P. (1995). Self-injurious behavior: Pathophysiology and implications for treatment. Journal of Clinical Psychiatry, 56, 580-588.
13.
Sellers, E. M. , Higgins, G. A., Tomkins, D. M., Romach, M. D., & Toneatto, T. (1991). Opportunities for treatment of psychoactive substance use disorders with serotonergic medications. Journal of Clinical Psychiatry, 52(Suppl. 12), 49-54.
14.
Smith, W. T. , & Glaudin, V. (1992). A placebo-controlled trial of paroxetine in the treatment of major depression. Journal of Clinical Psychiatry, 53(Suppl. 2), 36-39.
15.
Soubrie, P. (1986). Reconciling the role of central serotonin neurons in human and animal behavior. The Behavioral and Brain Sciences, 9, 319-364.
16.
Stein, D. J. , Hollander, E., & Liebowitz, M. R. (1993). Neurobiology of impulsivity and impulse control disorders. Journal of Neuropsychiatry and Clinical Neuroscience, 5, 9-17.
17.
Stuppaeck, C. H. , Geretsegger, C., Whitworth, A., Schubert, H., Platz, T., Konig, P., Hinterhuber, H., & Fleischhacker, W. W. (1994). A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatients. Journal of Clinical Psychopharmacology, 14, 241-246.
